Concord Biotech Limited
MainboardlistedCONCORDBIOINE338H01029- DRHP filed17 Aug 22
- RHP filed28 Jul 23
- Open04 Aug 23
- Close08 Aug 23
- Listed18 Aug 23
Issue
- Price band
- ₹705–741
- Issue price
- ₹741
- Face value
- ₹1
- Lot size
- 20
- Issue size
- ₹1,550.52 Cr
- Fresh / OFS
- not stated yet / ₹1,550.52 Cr
- Issue type
- book built
- Registrar
- Link Intime India Private Limited
- Exchanges
- BSE, NSE
- Sector
- Healthcare
- Industry
- Pharmaceuticals
Returns
- Listing
- +27.2%
- 1 month
- +35.3%
- 3 months
- +66.3%
- 6 months
- +90.1%
- 1 year
- +121.6%
- Current (03 Nov 26)
- +65.7%
Financials · from the offer document, ₹ crore
| Period | Revenue | EBITDA | PAT | Net worth | Borrowings | Total assets |
|---|---|---|---|---|---|---|
| FY21 | 234.9 | 999.4 | ||||
| FY23 | 240.1 | 1,290 | ||||
| FY31 | 174.9 | 1,103.2 |
Reservation · share of the net issue the offer document allocates to each category
- qib
- 50%
- nii
- 15%
- retail
- 35%
Subscription
| Category | Exchange | Times subscribed |
|---|---|---|
| bnii | NSE | 5.67× |
| employee | NSE | 11.38× |
| nii | NSE | 5.33× |
| qib | NSE | 21.10× |
| retail | NSE | 1.58× |
| snii | NSE | 4.64× |
| total | NSE | 7.96× |
Lead managers
Citigroup Global Markets India Private Limited · Jefferies India Private Limited · Kotak Mahindra Capital Company Limited